|
|
| (18 intermediate revisions by the same user not shown) |
| Line 23: |
Line 23: |
| |- | | |- |
| |} | | |} |
|
| |
| ==2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes<ref name="pmid37622663">{{cite journal| author=Marx N, Federici M, Schütt K, Müller-Wieland D, Ajjan RA, Antunes MJ | display-authors=etal| title=2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. | journal=Eur Heart J | year= 2023 | volume= 44 | issue= 39 | pages= 4043-4140 | pmid=37622663 | doi=10.1093/eurheartj/ehad192 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=37622663 }} </ref>==
| |
| ===Recommendations for diagnosing diabetes<ref name="pmid37622663">{{cite journal| author=Marx N, Federici M, Schütt K, Müller-Wieland D, Ajjan RA, Antunes MJ | display-authors=etal| title=2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. | journal=Eur Heart J | year= 2023 | volume= 44 | issue= 39 | pages= 4043-4140 | pmid=37622663 | doi=10.1093/eurheartj/ehad192 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=37622663 }} </ref>===
| |
|
| |
|
| |
| {|class="wikitable"
| |
| |-
| |
| | colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]]
| |
|
| |
| |-
| |
| | bgcolor="LightGreen"|"'''1.'''Screening for diabetes is recommended in all individuals with CVD, using fasting glucose and/or HbA1C<ref name="pmid33298413">{{cite journal| author=American Diabetes Association| title=2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. | journal=Diabetes Care | year= 2021 | volume= 44 | issue= Suppl 1 | pages= S15-S33 | pmid=33298413 | doi=10.2337/dc21-S002 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=33298413 }} </ref><ref name="pmid20978099">{{cite journal| author=Colagiuri S, Lee CM, Wong TY, Balkau B, Shaw JE, Borch-Johnsen K | display-authors=etal| title=Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes. | journal=Diabetes Care | year= 2011 | volume= 34 | issue= 1 | pages= 145-50 | pmid=20978099 | doi=10.2337/dc10-1206 | pmc=3005450 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20978099 }} </ref><ref name="pmid27216887">{{cite journal| author=Sattar N, Preiss D| title=Diabetic microvascular complications as simple indicators of risk for cardiovascular outcomes and heart failure. | journal=Lancet Diabetes Endocrinol | year= 2016 | volume= 4 | issue= 7 | pages= 555-6 | pmid=27216887 | doi=10.1016/S2213-8587(16)30097-3 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27216887 }} </ref><ref name="pmid35022686">{{cite journal| author=Mak KH, Vidal-Petiot E, Young R, Sorbets E, Greenlaw N, Ford I | display-authors=etal| title=Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities. | journal=Eur J Prev Cardiol | year= 2022 | volume= 28 | issue= 16 | pages= 1795-1806 | pmid=35022686 | doi=10.1093/eurjpc/zwab011 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=35022686 }} </ref> ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: A]])''"
| |
| |-
| |
| | bgcolor="LightGreen"|”'''2.'''It is recommended that the diagnosis of diabetes is based on HbA1C and/or fasting plasma glucose, or on an OGTT if still in doubt<ref name="pmid12502614">{{cite journal| author=Expert Committee on the Diagnosis and Classification of Diabetes Mellitus| title=Report of the expert committee on the diagnosis and classification of diabetes mellitus. | journal=Diabetes Care | year= 2003 | volume= 26 Suppl 1 | issue= | pages= S5-20 | pmid=12502614 | doi=10.2337/diacare.26.2007.s5 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12502614 }} </ref><ref name="pmid20067953">{{cite journal| author=Cowie CC, Rust KF, Byrd-Holt DD, Gregg EW, Ford ES, Geiss LS | display-authors=etal| title=Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. | journal=Diabetes Care | year= 2010 | volume= 33 | issue= 3 | pages= 562-8 | pmid=20067953 | doi=10.2337/dc09-1524 | pmc=2827508 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20067953 }} </ref><ref name="pmid30425094">{{cite journal| author=Arslanian S, Bacha F, Grey M, Marcus MD, White NH, Zeitler P| title=Evaluation and Management of Youth-Onset Type 2 Diabetes: A Position Statement by the American Diabetes Association. | journal=Diabetes Care | year= 2018 | volume= 41 | issue= 12 | pages= 2648-2668 | pmid=30425094 | doi=10.2337/dci18-0052 | pmc=7732108 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30425094 }} </ref>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''"
| |
| |}
| |
|
| |
| ===Recommendations for assessing cardiovascular risk in patients with type 2 diabetes<ref name="pmid37622663">{{cite journal| author=Marx N, Federici M, Schütt K, Müller-Wieland D, Ajjan RA, Antunes MJ | display-authors=etal| title=2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. | journal=Eur Heart J | year= 2023 | volume= 44 | issue= 39 | pages= 4043-4140 | pmid=37622663 | doi=10.1093/eurheartj/ehad192 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=37622663 }} </ref>===
| |
|
| |
| {|class="wikitable"
| |
| |-
| |
| | colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]]
| |
| |-
| |
| | bgcolor="LightGreen"|"'''1.''' It is recommended to screen patients with diabetes for the presence of severe TOD (target organ damage)<ref name="pmid23013602">{{cite journal| author=Fox CS, Matsushita K, Woodward M, Bilo HJ, Chalmers J, Heerspink HJ | display-authors=etal| title=Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. | journal=Lancet | year= 2012 | volume= 380 | issue= 9854 | pages= 1662-73 | pmid=23013602 | doi=10.1016/S0140-6736(12)61350-6 | pmc=3771350 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23013602 }} </ref><ref name="pmid27216886">{{cite journal| author=Brownrigg JR, Hughes CO, Burleigh D, Karthikesalingam A, Patterson BO, Holt PJ | display-authors=etal| title=Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study. | journal=Lancet Diabetes Endocrinol | year= 2016 | volume= 4 | issue= 7 | pages= 588-97 | pmid=27216886 | doi=10.1016/S2213-8587(16)30057-2 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27216886 }} </ref>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: A]])''"
| |
| |-
| |
| | bgcolor="LightGreen"|”'''2.'''It is recommended to asses medical history and the presence of symptoms suggestive of ASCVD (Atherosclerotic cardiovascular disease) in patients with diabetes<ref name="pmid33496366">{{cite journal| author=Ling J, Koye D, Buizen L, Khunti K, Montvida O, Paul SK| title=Temporal trends in co-morbidities and cardiometabolic risk factors at the time of type 2 diabetes diagnosis in the UK. | journal=Diabetes Obes Metab | year= 2021 | volume= 23 | issue= 5 | pages= 1150-1161 | pmid=33496366 | doi=10.1111/dom.14323 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=33496366 }} </ref><ref name="pmid21403036">{{cite journal| author=Wannamethee SG, Shaper AG, Whincup PH, Lennon L, Sattar N| title=Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors. | journal=Arch Intern Med | year= 2011 | volume= 171 | issue= 5 | pages= 404-10 | pmid=21403036 | doi=10.1001/archinternmed.2011.2 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21403036 }} </ref><ref name="pmid31301314">{{cite journal| author=Nelson AJ, Peterson ED, Pagidipati NJ| title=Atherosclerotic cardiovascular disease and heart failure: Determinants of risk and outcomes in patients with diabetes. | journal=Prog Cardiovasc Dis | year= 2019 | volume= 62 | issue= 4 | pages= 306-314 | pmid=31301314 | doi=10.1016/j.pcad.2019.07.001 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31301314 }} </ref>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''"
| |
| |-
| |
| | bgcolor="LightGreen"|”'''3.'''In patients with T2DM without symptomatic ASCVD or severe TOD, it is recommended to estimate 10-year CVD risk via SCORE2-Diabetes''<ref name="pmid37247330">{{cite journal| author=SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration| title=SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe. | journal=Eur Heart J | year= 2023 | volume= 44 | issue= 28 | pages= 2544-2556 | pmid=37247330 | doi=10.1093/eurheartj/ehad260 | pmc=10361012 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=37247330 }} </ref>([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''"
| |
| |}
| |
|
| |
| ==References==
| |
| {{Reflist|2}}
| |
| {{WH}}{{WS}}
| |